SGP
SpyGlass Pharma, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$28.94
−0.17%Institutional positioning
13F filings over the trailing two quarters
New 35Increased 0Reduced 0Sold out 35
| Filer | Action | Shares | Filed |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | New Position | 8,021,117 | May 15, 2026 |
| NEA MANAGEMENT COMPANY, LLC | New Position | 7,392,301 | May 15, 2026 |
| SANDS CAPITAL VENTURES, LLC | New Position | 2,500,012 | May 8, 2026 |
| SAMSARA BIOCAPITAL, LLC | New Position | 2,109,953 | May 15, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | New Position | 704,440 | May 15, 2026 |
| VESTAL POINT CAPITAL, LP | New Position | 666,760 | May 15, 2026 |
| JPMORGAN CHASE & CO | New Position | 577,109 | May 13, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | New Position | 550,000 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | New Position | 468,794 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 434,813 | May 15, 2026 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | New Position | 375,000 | May 15, 2026 |
| FRANKLIN RESOURCES INC | New Position | 300,000 | May 13, 2026 |
| AFFINITY ASSET ADVISORS, LLC | New Position | 250,000 | May 14, 2026 |
| ABRDN PLC | New Position | 220,454 | Apr 29, 2026 |
| BLACKROCK, INC. | New Position | 144,739 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings